- Home
- NRSN vs NXN Comparison
NRSN vs NXN Comparison
Compare NRSN & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- NXN
- Stock Information
- Founded
- NRSN 2017
- NXN 1992
- Country
- NRSN Israel
- NXN United States
- Employees
- NRSN N/A
- NXN N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- NXN Trusts Except Educational Religious and Charitable
- Sector
- NRSN Health Care
- NXN Finance
- Exchange
- NRSN Nasdaq
- NXN Nasdaq
- Market Cap
- NRSN 50.1M
- NXN 45.4M
- IPO Year
- NRSN 2021
- NXN N/A
- Fundamental
- Price
- NRSN $1.06
- NXN $11.76
- Analyst Decision
- NRSN Buy
- NXN
- Analyst Count
- NRSN 2
- NXN 0
- Target Price
- NRSN $14.00
- NXN N/A
- AVG Volume (30 Days)
- NRSN 353.2K
- NXN 9.7K
- Earning Date
- NRSN 09-29-2025
- NXN 01-01-0001
- Dividend Yield
- NRSN N/A
- NXN 4.23%
- EPS Growth
- NRSN N/A
- NXN N/A
- EPS
- NRSN N/A
- NXN 0.24
- Revenue
- NRSN N/A
- NXN N/A
- Revenue This Year
- NRSN N/A
- NXN N/A
- Revenue Next Year
- NRSN N/A
- NXN N/A
- P/E Ratio
- NRSN N/A
- NXN $48.42
- Revenue Growth
- NRSN N/A
- NXN N/A
- 52 Week Low
- NRSN $0.68
- NXN $10.64
- 52 Week High
- NRSN $2.60
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- NRSN 33.59
- NXN 61.84
- Support Level
- NRSN $1.05
- NXN $11.60
- Resistance Level
- NRSN $1.17
- NXN $11.78
- Average True Range (ATR)
- NRSN 0.12
- NXN 0.08
- MACD
- NRSN 0.01
- NXN 0.00
- Stochastic Oscillator
- NRSN 10.00
- NXN 92.59
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.